The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
Open accessAbstract
OBJECTIVE: In diabetes, vascular dysfunction is characterized by impaired endothelial function due to increased oxidative stress. Empagliflozin, as a selective sodium-glucose co-transporter 2 inhibitor (SGLT2i), offers a novel approach for the treatment of type 2 diabetes by enhancing urinary glucose excretion. The aim of the present study was to test whether treatment with empagliflozin improves endothelial dysfunction in type I diabetic rats via reduction of glucotoxicity and associated vascular oxidative stress. METHODS: Type I diabetes in Wistar rats was induced by an intravenous injection of streptozotocin (60 mg/kg). One week after injection empagliflozin (10 and 30 mg/kg/d) was administered via drinking water for 7 weeks. Vascular function was assessed by isometric tension recording, oxidative stress parameters by chemiluminescence and fluorescence techniques, protein expression by Western blot, mRNA expression by RT-PCR, and islet function by insulin ELISA in serum and immunohistochemical staining of pancreatic tissue. Advanced glycation end products (AGE) signaling was assessed by dot blot analysis and mRNA expression of the AGE-receptor (RAGE). RESULTS: Treatment with empagliflozin reduced blood glucose levels, normalized endothelial function (aortic rings) and reduced oxidative stress in aortic vessels (dihydroethidium staining) and in blood (phorbol ester/zymosan A-stimulated chemiluminescence) of diabetic rats. Additionally, the pro-inflammatory phenotype and glucotoxicity (AGE/RAGE signaling) in diabetic animals was reversed by SGLT2i therapy. CONCLUSIONS: Empagliflozin improves hyperglycemia and prevents the development of endothelial dysfunction, reduces oxidative stress and improves the metabolic situation in type 1 diabetic rats. These preclinical observations illustrate the therapeutic potential of this new class of antidiabetic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,187
Self-citationMetabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U. C., & Woerle, H.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72227 · Cited by 1,134 · cited 1×
“Along these lines SGLT2 inhibitors have been demonstrated to be effective in diabetes mellitus type II [35] and are anticipated to be also effective in type 1 diabetic patients.”
BackgroundActivation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart
Chen, C.-H., Budas, G. R., Churchill, E. N., Disatnik, M.-H., Hurley, T. D., & Mochly-Rosen, D. (2008) · Science · doi:10.1126/science.1158554 · Cited by 767
Grempler, R., Thomas, L., Eckhardt, M., Himmelsbach, F., Sauer, A., Sharp, D. E., Bakker, R. A., Mark, M., Klein, T., & Eickelmann, P. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01517.x · Cited by 608
Identification of the enzymatic mechanism of nitroglycerin bioactivation
Chen, Z., Zhang, J., & Stamler, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225199 · Cited by 541
Wenzel, P., Knorr, M., Kossmann, S., Stratmann, J., Hausding, M., Schuhmacher, S., Karbach, S. H., Schwenk, M., Yogev, N., Schulz, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034470 · Cited by 504
Self-citationBierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 495
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Coughlan, M. T., Thorburn, D. R., Penfold, S. A., Laskowski, A., Harcourt, B. E., Sourris, K. C., Tan, A. L. Y., Fukami, K., Thallas-Bonke, V., Nawroth, P. P., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050514 · Cited by 472
Cherney, D. Z., Perkins, B. A., Soleymanlou, N., Har, R., Fagan, N., Johansen, O., Woerle, H.-J., von Eynatten, M., & Broedl, U. C. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-28 · Cited by 470
Oxidative stress and diabetic cardiovascular complications
Jay, D., Hitomi, H., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.018 · Cited by 464
Wautier, J. L., Wautier, M. P., Schmidt, A. M., Anderson, G. M., Hori, O., Zoukourian, C., Capron, L., Chappey, O., Yan, S. D., & Brett, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7742 · Cited by 353
Rieg, T., Masuda, T., Gerasimova, M., Mayoux, E., Platt, K., Powell, D. R., Thomson, S. C., Koepsell, H., & Vallon, V. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00518.2013 · Cited by 310
Self-citationSydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Self-citationForbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Schulz, E., Wenzel, P., Münzel, T., & Daiber, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4609 · Cited by 251
Self-citationKröller-Schön, S., Steven, S., Kossmann, S., Scholz, A., Daub, S., Oelze, M., Xia, N., Hausding, M., Mikhed, Y., Zinßius, E., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4953 · Cited by 248
Self-citationLin, M. I., Fulton, D., Babbitt, R., Fleming, I., Busse, R., Pritchard, K. A., & Sessa, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302836200 · Cited by 236
Perkins, B. A., Cherney, D. Z. I., Partridge, H., Soleymanlou, N., Tschirhart, H., Zinman, B., Fagan, N. M., Kaspers, S., Woerle, H.-J., Broedl, U. C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2338 · Cited by 231
Oelze, M., Daiber, A., Brandes, R. P., Hortmann, M., Wenzel, P., Hink, U., Schulz, E., Mollnau, H., von Sandersleben, A., Kleschyov, A. L., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000239207.82326.29 · Cited by 203
Self-citationFerrannini, E., Seman, L., Seewaldt‐Becker, E., Hantel, S., Pinnetti, S., & Woerle, H. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12081 · Cited by 181
Daiber, A., Oelze, M., Coldewey, M., Bachschmid, M., Wenzel, P., Sydow, K., Wendt, M., Kleschyov, A. L., Stalleicken, D., Ullrich, V., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002600 · Cited by 177
Self-citationKröller-Schön, S., Knorr, M., Hausding, M., Oelze, M., Schuff, A., Schell, R., Sudowe, S., Scholz, A., Daub, S., Karbach, S., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs246 · Cited by 174
Self-citationWenzel, P., Hink, U., Oelze, M. W., Schuppan, S., Schaeuble, K., Schildknecht, S., Ho, K. K., Weiner, H., Bachschmid, M. M., Münzel, T. F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606477200 · Cited by 167
Self-citationLoot, A. E., Schreiber, J. G., Fißlthaler, B., & Fleming, I. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090449 · Cited by 147
Oelze, M. W., Kröller‐Schön, S., Steven, S., Lubos, E., Doppler, C. E. J., Hausding, M., Tobias, S., Brochhausen, C., Li, H., Torzewski, M., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01602 · Cited by 136
Self-citationWenzel, P., Daiber, A., Oelze, M. W., Brandt, M., Closs, E. I., Xu, J., Thum, T., Bauersachs, J. K., Ertl, G., Zou, M., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.003 · Cited by 135
Self-citationWang, J., Wang, H., Hao, P., Li, X., Wei, S., Zhang, Y. L., & Chen, Y. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00114 · Cited by 135
Wenzel, P., Schulz, E., Oelze, M. W., Müller, J., Schuhmacher, S., Alhamdani, M. S. S., Debrezion, J., Hortmann, M., Reifenberg, K., Fleming, I., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.009 · Cited by 115
Self-citationJeong, K.-H., Lee, T., Ihm, C., Lee, S., Moon, J., & Lim, S. (2008) · American Journal of Nephrology · doi:10.1159/000158635 · Cited by 96
Schuhmacher, S., Oelze, M. W., Bollmann, F., Kleinert, H., Otto, C., Heeren, T. F. C., Steven, S., Hausding, M., Knorr, M., Pautz, A., et al. (2011) · Diabetes · doi:10.2337/db10-1395 · Cited by 94
Self-citationPricci, F., Leto, G., Amadio, L., Iacobini, C., Cordone, S., Catalano, S., Zicari, A., Sorcini, M., Mario, U. D., & Pugliese, G. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00401-5 · Cited by 90
Sarashina, A., Koiwai, K., SEMAN, L. J., Yamamura, N., Taniguchi, A., Negishi, T., Sesoko, S., Woerle, H. J., & Dugi, K. A. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-082 · Cited by 86
Luippold, G., Klein, T., Mark, M., & Grempler, R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01569.x · Cited by 79
Wenzel, P., Hink, U., Oelze, M. W., Seeling, A., Isse, T., Bruns, K., Steinhoff, L., Brandt, M., Kleschyov, A. L., Schulz, E., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707116 · Cited by 78
Self-citationHausding, M., Jurk, K., Daub, S., Kröller‐Schön, S., Stein, J., Schwenk, M., Oelze, M. W., Mikhed, Y., Kerahrodi, J. G., Kossmann, S., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0386-5 · Cited by 78
Self-citationKumar, S., Prasad, S., & Sitasawad, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067009 · Cited by 73
Yu, Y., & Lyons, T. J. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200511000-00005 · Cited by 71
Roles of the AGE‐RAGE System in Vascular Injury in Diabetesa
Yamamoto, Y., Yamagishi, S., Yonekura, H., Doi, T., Tsuji, H., KATO, I., Takasawa, S., OKAMOTO, H., Abedin, J., Tanaka, N., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06311.x · Cited by 69
Sun, M., Yokoyama, M., Ishiwata, T., & Asano, G. (1998) · PubMed · Cited by 67
Vickers, S. P., Cheetham, S. C., Headland, K. R., Dickinson, K., Grempler, R., Mayoux, E., Mark, M., & Klein, T. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s58786 · Cited by 62
Self-citationHansen, H. H., Jelsing, J., Hansen, C. F., Hansen, G., Vrang, N., Mark, M., Klein, T., & Mayoux, E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213454 · Cited by 61
Self-citationOelze, M. W., Knorr, M., Schuhmacher, S., Heeren, T. F. C., Otto, C., Schulz, E., Reifenberg, K., Wenzel, P., Münzel, T. F., & Daiber, A. (2011) · Journal of Vascular Research · doi:10.1159/000320627 · Cited by 49
Self-citationAging and Insulin Resistance: Just Say iNOS
Evans, J. L., & Goldfine, I. D. (2013) · Diabetes · doi:10.2337/db12-1239 · Cited by 47
Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro
Oelze, M. W., Knorr, M., Schell, R., Kamuf, J., Pautz, A., Art, J., Wenzel, P., Münzel, T. F., Kleinert, H., & Daiber, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190017 · Cited by 43
Self-citationШиряева, Ю. К., Vv, K., & Титов, В. Н. (2012) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-012-1656-1 · Cited by 5
Cited by
The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing
Deng, L., Du, C., Song, P., Chen, T., Rui, S., Armstrong, D. G., & Deng, W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8852759 · Cited by 763
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Self-citationBhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000691 · Cited by 639
Uthman, L., Baartscheer, A., Bleijlevens, B., Schumacher, C. A., Fiolet, J. W. T., Koeman, A., Jancev, M., Hollmann, M. W., Weber, N. C., Coronel, R., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4509-7 · Cited by 610
Metadata
- Authors
- Oelze, M., Kröller-Schön, S., Welschof, P., Jansen, T., Hausding, M., Mikhed, Y., Stamm, P., Mader, M., Zinßius, E., Agdauletova, S., Gottschlich, A., Steven, S., Schulz, E., Bottari, S. P., Mayoux, E., Münzel, T., & Daiber, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-11-17
- Volume
- 9
- Issue
- 11
- Pages
- e112394
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2083485319
- Cited by
- 293
- References
- 48
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.